MET and neoplasm: Subsequent investigations revealed that tumors with MET amplification displayed reduced levels of STING and less infiltration of CTLs and NK cells, and decreased tumor immunogenicity of the MET-amplified tumor microenvironment was confirmed by single-cell RNA sequencing.